期刊文献+

急性皮肤型移植物抗宿主病8例临床分析并文献复习 被引量:2

Clinical analysis of 8 cases with acute cutaneous graft versus host disease and literature review
下载PDF
导出
摘要 目的:初步探讨异基因造血干细胞移植(allo-HSCT)后急性皮肤型移植物抗宿主病(GVHD)的临床特征,为早期诊断和治疗提供临床依据。方法:对2012年12月—2013年12月期间就诊的8例急性皮肤型GVHD患者进行观察和临床资料分析,并结合文献讨论其早期诊断和治疗方法、发病危险因素和预防措施。结果:8例患者原发病分别为:急性单核细胞白血病(2例),急性混合细胞白血病(1例),慢性粒细胞白血病(2例),急性重型再生障碍性贫血(2例),非霍奇金淋巴瘤(1例)。血缘人类白细胞抗原(HLA)全相合者5例,半相合者3例。8例患者中女4例,男4例,移植后GVHD发生时间为15 d^3个月,临床表现大多为弥漫性红斑、斑丘疹,1例表现为特征性的毛囊周围丘疹,结合皮损组织病理检查明确诊断,给予糖皮质激素联合免疫抑制剂治疗,8例患者病情均得到有效控制。结论:allo-HSCT后急性皮肤型GVHD临床表现大多无特异性,需结合病史和组织病理检查明确诊断,早期治疗预后良好。 Objective: To investigate the clinical characteristics of acute cutaneous graft versus host disease(GVHD) after allogeneic hematopoietic stem cell transplantation(allo-HSCT), and to provide clinical evidence for early diagnosis and treatment. Methods: We analyzed clinical data from 8 patients with acute cutaneous GVHD in our department from December 2012 to December 2013. Early diagnosis and treatment, risk factors and preventive measures of acute cutaneous GVHD were discussed with literature review. Results: The primary diseases of 8 patients, 4 males and 4 females, included acute monocytic leukemia(2 cases), mixed-lineage acute leukemia(1 case), chronic myelocytic leukemia (2 cases), acute severe aplastic anemia (2 cases), and non-Hodgkin lymphoma(1 case). 5 patients were blood human leucocyte antigen(HLA)-identical, and 3 were HLA-haploidentical. GVHD occurred 15 days to three months after transplantation. Most of patients presented with diffused erythemas and maculopapules. 1 case showed typical perifollicular papules. Diagnosis was made based on clinical manifestations and histopathological examination. Disease was under control with glucocorticoids and immunosuppressant in all 8 patients. Conclusion: The acute cutaneous GVHD has no specific clinical manifestations. Medical history and histopatho- logical examination are helpful for diagnosis. Early treatment could result in favorable prognosis.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2015年第11期682-684,共3页 Journal of Clinical Dermatology
关键词 移植物抗宿主病 皮肤型 急性 异基因造血干细胞移植 graft versus host disease, cutaneous, acute allogeneic hematopoietic stem cell transplantation
  • 相关文献

参考文献7

  • 1Creamer D, Martyn-Simmons CL, Osborne G, et al. Eezematoid graft-vs-host disease-a novel form of chronic cutaneous graft- vs-host disease and its response to psoralen UVA therapy IJ1- Arch Dermatol,2007,143(9): 1157-1162.
  • 2lzumi R, Fujimoto M, Yazawa N, et al. Bullous pemphigoid post-tire for anti-BPlSO and anti-laminin 5 antibodies in a patient with graft-vs-host disease [J]. J Am Acad Dermatol, 2007, 56(5): S94-S97.
  • 3Doherty C, Ulitsky O, Petronie-Rosic V. Erythema muhiformee- like presentation of ehronie graft versus host disease [J]. J Am Aead Dennatol, 2008, 59(5): S127-S128.
  • 4魏瑾,张宇,徐宏俊,杜娟,陈周,蔡林,李文海,张建中.表现为特应性皮炎的移植物抗宿主病11例临床分析[J].临床皮肤科杂志,2012,41(11):652-654. 被引量:8
  • 5刘萍,张建中.皮肤移植物抗宿主病[J].中华皮肤科杂志,2013,46(10):764-767. 被引量:11
  • 6周颖,陈宝安,赵刚.急性GVHD的治疗研究新进展[J].中国实验血液学杂志,2010,18(1):238-241. 被引量:8
  • 7Zeighami S, Hadjibabaie M, Ashouri A, et al. Assessment of cy- closporine serum concentrations on the incidence of acute graft versus host disease post hematopoietic stem cell transplantation [J]. lran J Pharm Res, 2014, 13(1): 305-312.

二级参考文献67

  • 1Deeg HJ. How I treat refractory acute GVHD. Blood, 2007; 109 (10) : 4119 -4126.
  • 2Bacigalupo A. Management of acute graft-versus-host disease. Br J Haematol,2007 ; 137 (2) : 87 - 98.
  • 3MacMillan ML, Weisdorf DJ, Wagner JE, et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease : comparison of grading systems. Biol Blood Marrow Transplant, 2002; 8(7):387-394.
  • 4Takahiro Fukuda, Tohihiro Takahashi, Yukiko Iisaka, et al. Primary treatment for acute graft versus host disease ( GVHD ) : a single-centre analysis of 458 japanese patients. Blood (ASH Annual Meeting Abstracts), Nov, 2007 ;110:4976.
  • 5Inagaki J, Nagatoshi Y, Hatano M, et al. Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children. Bone Marrow Transplant, 2008; 41 (6) : 571 -577.
  • 6Carpenter PA, Sanders JE. Steroid-refractory graft vs host disease: past, present and future. Pediatric : Transplant, 2003 ; 7 ( Suppl. 3) : 19 -31.
  • 7Knop S, Hebart H, Gscheidle H, et al. OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease. Bone Marrow Transplant,2005 ; 36(9 ) : 831 - 837.
  • 8Knop S, Hebart H, Gratwohl A, et al. Treatment of steroidresistant acute GVHD with OKT3 and high-dose steroids results in better disease control and lower incidence of infectious complic- ations when compared to high-dose steroids alone: a randomized multicenter trial by the EBMT Chronic Leukemia Working Party. Leukemia, 2007; 21(8) : 1830-1833.
  • 9Macmillan ML, Couriel D, Weisdorf DJ, et al. A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease. Blood,2007 ; 109 (6) : 2657 - 2662.
  • 10Miano M, Cuzzubbo D, Terranova P, et al. Daclizumab as useful treatment in refractory acute GVHD: a paediatric experience. Bone Marrow Transplant, 2009 ; 43 ( 5 ) : 423 - 427.

共引文献22

同被引文献16

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部